MediaAlpha Earnings Calls
| Release date | Apr 29, 2026 |
| EPS estimate | $0.250 |
| EPS actual | $0.210 |
| EPS Surprise | -16.00% |
| Revenue estimate | 298.913M |
| Revenue actual | 310.004M |
| Revenue Surprise | 3.71% |
| Release date | Feb 23, 2026 |
| EPS estimate | $0.250 |
| EPS actual | $0.500 |
| EPS Surprise | 100.00% |
| Revenue estimate | 295.018M |
| Revenue actual | 291.155M |
| Revenue Surprise | -1.31% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.210 |
| EPS actual | $0.260 |
| EPS Surprise | 23.81% |
| Revenue estimate | 296.421M |
| Revenue actual | 306.514M |
| Revenue Surprise | 3.41% |
| Release date | Aug 06, 2025 |
| EPS estimate | $0.160 |
| EPS actual | $0.170 |
| EPS Surprise | 6.25% |
| Revenue estimate | 248.801M |
| Revenue actual | 251.622M |
| Revenue Surprise | 1.13% |
Last 4 Quarters for MediaAlpha
Below you can see how MAX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $10.35 |
| EPS estimate | $0.160 |
| EPS actual | $0.170 |
| EPS surprise | 6.25% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $10.02 |
| Aug 01, 2025 | $9.86 |
| Aug 04, 2025 | $10.48 |
| Aug 05, 2025 | $10.14 |
| Aug 06, 2025 | $10.35 |
| Aug 07, 2025 | $11.39 |
| Aug 08, 2025 | $10.95 |
| Aug 11, 2025 | $9.56 |
| Aug 12, 2025 | $9.83 |
| 4 days before | 3.29% |
| 4 days after | -5.02% |
| On release day | 10.05% |
| Change in period | -1.90% |
| Release date | Oct 29, 2025 |
| Price on release | $11.12 |
| EPS estimate | $0.210 |
| EPS actual | $0.260 |
| EPS surprise | 23.81% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $11.29 |
| Oct 24, 2025 | $11.51 |
| Oct 27, 2025 | $11.41 |
| Oct 28, 2025 | $11.28 |
| Oct 29, 2025 | $11.12 |
| Oct 30, 2025 | $12.23 |
| Oct 31, 2025 | $12.75 |
| Nov 03, 2025 | $13.26 |
| Nov 04, 2025 | $13.35 |
| 4 days before | -1.51% |
| 4 days after | 20.05% |
| On release day | 9.98% |
| Change in period | 18.25% |
| Release date | Feb 23, 2026 |
| Price on release | $7.77 |
| EPS estimate | $0.250 |
| EPS actual | $0.500 |
| EPS surprise | 100.00% |
| Date | Price |
|---|---|
| Feb 17, 2026 | $7.33 |
| Feb 18, 2026 | $7.42 |
| Feb 19, 2026 | $7.67 |
| Feb 20, 2026 | $7.84 |
| Feb 23, 2026 | $7.77 |
| Feb 24, 2026 | $8.97 |
| Feb 25, 2026 | $9.60 |
| Feb 26, 2026 | $9.90 |
| Feb 27, 2026 | $9.94 |
| 4 days before | 6.00% |
| 4 days after | 27.93% |
| On release day | 15.44% |
| Change in period | 35.61% |
| Release date | Apr 29, 2026 |
| Price on release | $10.00 |
| EPS estimate | $0.250 |
| EPS actual | $0.210 |
| EPS surprise | -16.00% |
| Date | Price |
|---|---|
| Apr 23, 2026 | $9.49 |
| Apr 24, 2026 | $9.60 |
| Apr 27, 2026 | $9.87 |
| Apr 28, 2026 | $10.01 |
| Apr 29, 2026 | $10.00 |
| Apr 30, 2026 | $8.51 |
| May 01, 2026 | $9.10 |
| May 04, 2026 | $8.89 |
| May 05, 2026 | $9.45 |
| 4 days before | 5.37% |
| 4 days after | -5.50% |
| On release day | -14.95% |
| Change in period | -0.421% |
MediaAlpha Earnings Call Transcript Summary of Q1 2026
MediaAlpha reported a strong start to 2026 with record Q1 results driven by a favorable mix shift toward its higher‑margin open marketplace. Revenue was $310 million (above guidance midpoint/high end) and adjusted EBITDA was $31.4 million, up 7% year‑over‑year, with 64% of contribution converting to adjusted EBITDA. Performance was led by P&C (auto) as more carriers increased spend; management sees broadening demand among top 15–20 carriers who still have meaningful runway to increase marketplace allocation. Management highlighted a potential secular tailwind from large LLMs (e.g., ChatGPT) shifting toward advertising monetization, which could accelerate referral traffic. The company launched an LLM‑powered consumer product (autoinsurance.net) as an early proof of concept. Under‑65 health continues to shrink as a percent of mix; Medicare Advantage remains the long‑term health opportunity. Balance sheet actions: refinanced with a $150M term loan and $60M revolver (matures March 2031), ended Q1 with $26.1M cash and $45M available on the revolver. Capital return: repurchased ~2.6M shares for $25M (~4% of the company) and plan to complete the majority of the remaining $60M of a $100M buyback authorization in 2026. Guidance changes: beginning in Q2 the company will stop reporting transaction value and will guide to contribution as the primary metric. Q2 guidance: revenue $290M–$310M, contribution $45.5M–$48.5M, adjusted EBITDA $28M–$30.5M (note: roughly $2M YoY decline in contribution from under‑65 health). Full‑year expectations include $90M–$100M in free cash flow and a normalization of P&C growth in H2 as prior‑year comps become tougher. Management reiterated focus on shareholder returns and disciplined capital allocation.
Sign In
Buy MAX